Compounded Semaglutide: Is a Prescription Required?

Yes. Every route that can lawfully put compounded semaglutide in your hands runs through a prescriber, and any seller telling you otherwise is describing a transaction that sits outside the pharmacy system rather than a shortcut through it. The more useful question is which route a seller is claiming, because the two federal ones do not carry the same requirement. That gap is where the misleading pitches live.

The two routes ask for different things

Compounding happens under one of two sections of federal law, and they are not interchangeable (503A vs 503B compounding pharmacies). A 503A pharmacy has to be working from a valid prescription written for a specific, identified patient. A 503B outsourcing facility can do that too, but it may also ship against an order from a health-care provider (a hospital, say) that names no individual patient at all.^[1]

So what is being sold without one?

Something that is not operating as a pharmacy. The sellers offering semaglutide or tirzepatide with no prescriber in the loop generally label the product as being for research, or as not for human consumption. That wording is not a product grade or a technicality. It is the seller’s legal position, in writing, about what they are handing you.

FDA has acted against companies using exactly those labels on unapproved GLP-1 products, and has said it is aware of counterfeit Ozempic reaching buyers in the United States. Its instruction for anyone purchasing medication online is a single sentence long: use a state-licensed pharmacy.^[2]

• “No prescription needed” means no clinician is accountable for your dose, your titration, or what happens if it goes wrong. It also means the product is not a GLP-1 drug sold lawfully, because no GLP-1 drug is available over the counter in the US.
• “Research use only” means the seller has told you in writing that this is not for you to inject, and that statement still stands after you buy.
• No named dispensing pharmacy leaves you nothing to look up in a state board register and no one to complain to.
• A checkout with no intake at all is a clear warning. A questionnaire that cannot be failed is a problem too, but a different and less obvious one.

A quick consult is still a consult

Plenty of legitimate telehealth runs on an asynchronous questionnaire rather than a video visit, and that is lawful in most of the country. Check whether a named, licensed prescriber signed off and whether a named pharmacy dispensed; how long it took matters less. Both details should be findable without asking. Where they are not, we say so in the provider register.

Sellers answer that in very different ways. JM Integrated Health is led by a nurse practitioner, John Meyer, who treats patients himself in the eight states it lists. SurpassMD connects patients with an independent medical group, and VivioMD says OpenLoop Healthcare Partners clinicians prescribe and that a live provider consult is included. G-Plans, a meal-plan subscription, also has OpenLoop’s medical group write its prescriptions, and shows no price until after the health intake. VivioMD also received an FDA warning letter over website labels that implied it compounds the drugs itself, a reminder that the seller and the pharmacy are usually different businesses.

What to ask, in order

1. Who is the prescriber, and are they licensed in my state? A name you can check, not “our medical team”.
2. Which pharmacy dispenses it? An unnamed “partner network” does not answer the question.
3. Is this the approved product or a compounded one? If compounded, on what basis now that the shortages have closed?
4. What happens if I have a reaction? A seller with no clinician cannot answer it.

Some services put the prescriber inside a program you may already have. Teladoc Health prescribes GLP-1s only to members whose employer or health plan offers an eligible program, Enara Health runs an insurance-billed obesity medicine program through partner clinics in five states, and T2D.com builds its prescriber-included service around type 2 diabetes and prediabetes. At the other end, OlleveCare names no medical director or pharmacy and does not say whether its drugs are compounded, and Vela Rx names neither its medical group nor its pharmacy, so the first two questions above are where to start with either of them.